Literature DB >> 16377173

Invasion is a genetic program regulated by transcription factors.

Bradford W Ozanne1, Heather J Spence, Lynn C McGarry, Robert F Hennigan.   

Abstract

The invasive and metastatic behaviour of tumours impacts crucially on the clinical management of cancer. Accordingly, it is important to understand the regulation of tumour cell invasiveness. Genetic analysis of worms, Drosophila and mice has provided evidence that invasion is a genetic pathway regulated by transcription factors that are often implicated in tumour cell invasion. Recent evidence has revealed much concerning the role of one particular transcription factor, AP1, which is involved in the regulation of a multigenic invasion program in which upregulated and downregulated genes function as invasion effectors and suppressors, respectively. Differentially expressed genes cooperatively enhance pseudopod elongation during the mesenchymal mode of invasion by altering the function, localisation and activity of non-differentially expressed proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377173     DOI: 10.1016/j.gde.2005.12.012

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  11 in total

Review 1.  Cell invasion through basement membrane: the anchor cell breaches the barrier.

Authors:  Elliott J Hagedorn; David R Sherwood
Journal:  Curr Opin Cell Biol       Date:  2011-05-31       Impact factor: 8.382

2.  Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; B Mark Evers; Miriam Falzon
Journal:  Regul Pept       Date:  2007-01-10

Review 3.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

4.  Promotion of breast cancer cells MDA-MB-231 invasion by di(2-ethylhexyl)phthalate through matrix metalloproteinase-2/-9 overexpression.

Authors:  Shuya Zhang; Jiehua Ma; Ziyi Fu; Zhilei Zhang; Jian Cao; Lei Huang; Wenqu Li; Pengfei Xu; Xin Cao
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-06       Impact factor: 4.223

5.  PTHrP promotes colon cancer cell migration and invasion in an integrin α6β4-dependent manner through activation of Rac1.

Authors:  Ramanjaneya V Mula; Vandanajay Bhatia; Miriam Falzon
Journal:  Cancer Lett       Date:  2010-07-15       Impact factor: 8.679

6.  SNAI2/Slug promotes growth and invasion in human gliomas.

Authors:  Hong Wei Yang; Lata G Menon; Peter M Black; Rona S Carroll; Mark D Johnson
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

Review 7.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.

Authors:  'Matladi N Ndlovu; Carine Van Lint; Karlien Van Wesemael; Pieter Callebert; Dany Chalbos; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

9.  Invasive Cell Fate Requires G1 Cell-Cycle Arrest and Histone Deacetylase-Mediated Changes in Gene Expression.

Authors:  David Q Matus; Lauren L Lohmer; Laura C Kelley; Adam J Schindler; Abraham Q Kohrman; Michalis Barkoulas; Wan Zhang; Qiuyi Chi; David R Sherwood
Journal:  Dev Cell       Date:  2015-10-26       Impact factor: 12.270

10.  Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis.

Authors:  Brian T Ragel; William T Couldwell; David L Gillespie; Randy L Jensen
Journal:  Neurosurg Rev       Date:  2007-05-08       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.